Correlation Between Day One and Nanobac Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Day One and Nanobac Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Nanobac Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Nanobac Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Day One and Nanobac Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Nanobac Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Nanobac Pharmaceuticals.
Diversification Opportunities for Day One and Nanobac Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Day and Nanobac is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Nanobac Pharmaceuticals Incorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanobac Pharmaceuticals and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Nanobac Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanobac Pharmaceuticals has no effect on the direction of Day One i.e., Day One and Nanobac Pharmaceuticals go up and down completely randomly.
Pair Corralation between Day One and Nanobac Pharmaceuticals
If you would invest 0.01 in Nanobac Pharmaceuticals Incorporated on October 7, 2024 and sell it today you would earn a total of 0.00 from holding Nanobac Pharmaceuticals Incorporated or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Nanobac Pharmaceuticals Incorp
Performance |
| Timeline |
| Day One Biopharmaceu |
| Nanobac Pharmaceuticals |
Day One and Nanobac Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Nanobac Pharmaceuticals
The main advantage of trading using opposite Day One and Nanobac Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Nanobac Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanobac Pharmaceuticals will offset losses from the drop in Nanobac Pharmaceuticals' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Nanobac Pharmaceuticals vs. Protokinetix | Nanobac Pharmaceuticals vs. Mymetics Corp | Nanobac Pharmaceuticals vs. Neutra Corp | Nanobac Pharmaceuticals vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |